We are a pharmaceutical accelerator company. Our goal is to efficiently shepherd promising drug candidates through the riskiest, early stages of development. We do this by identifying innovative and transformative therapeutics and efficiently launching companies focused on preclinical drug development.
Ascend BioVentures’ Advisory Committee (AC) was developed to provide objective, external perspective and quality authentication on potential drug development projects and companies. The AC members provide diverse perspectives and non-binding feedback to Ascend BioVentures as it relates to its R&D activities, portfolio of projects, and decisions regarding company formation.
AC members have the opportunity to review new technologies and potentially engage with spin-out portfolio companies as management, consultants, investors, board members, or downstream partners.
Members of the AC include representatives from mid-sized to large pharmaceutical companies, experienced pharmaceutical industry executives, as well as venture capitalists.